Lilly's (LLY) Subsidiary Elanco Animal Health's (ELAN) IPO Prices at $24/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/26/2026
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Stock action shows confidence in central banks: BofA’s Hartnett
- Oil prices slide about 2% as US, Iran explore path out of war
- Why stocks held up despite rising yields and $100 oil? These 2 words explain it
- Barclays asks if equity markets are nearing the boiling point
- White House blocks CNN from Air Force One trip, Washington Post reports
- Merck and Daiichi Sankyo withdraw lung cancer drug application
- Exclusive-SK Hynix's Solidigm weighs IPO that could value the unit at up to $150 billion, sources say
- Fox Factory sells Marucci Sports for $225M, cuts debt
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
Elanco Announces Pricing of Initial Public Offering
September 19, 2018 5:12 PM EDTGREENFIELD, Ind.--(BUSINESS WIRE)-- Elanco Animal Health Incorporated, a subsidiary of Eli Lilly and Company (NYSE: LLY), announced today the pricing of its initial public offering (IPO) of 62.9 million shares of its common stock at a price to the public of $24.00 per share. The shares are expected to begin trading on the New York Stock Exchange (NYSE) on September 20, 2018 under the ticker symbol ELAN. The offering is expected to close on September 24, 2018, subject to customary closing conditions.
Elanco has granted the underwriters a 30-day option to purchase up to 9.435 million... More
